Novocure Reports Data Showing TTF Therapy in Combination With Chemotherapy Has the Potential to Increase Overall Survival for Patients With Advanced Non-Small Cell Lung Cancer

Data Presented Today at the 35th European Society for Medical Oncology Congress

MILAN, October 10, 2010 – Novocure reported today that patients with advanced non-small cell lung
cancer (NSCLC) achieved a significant increase in survival time when tumor
treating fields (TTF) therapy was added to chemotherapy, as compared to
previously reported outcomes for patients receiving chemotherapy alone. Dr.
Miklos [...]

Eisai’s Eribulin Mesylate Maintains Overall Survival Benefit in Patients With Metastatic Breast Cancer, Irrespective of Tumour Hormone Receptor Status

Results From the EMBRACE Study Reinforce Efficacy of Eribulin Across Several Patient Sub-Groups

MILAN, October 10, 2010 – Further results from the Phase III EMBRACE study presented today at the
European Society of Medical Oncology (ESMO) congress showed that Eisai's
eribulin mesylate maintained an overall survival (OS) benefit compared with
Treatment of Physician's Choice (TPC) in metastatic breast [...]

ArQule and Daiichi Sankyo Expand Drug Discovery Collaboration in Oncology

WOBURN, Massachusetts, October 12, 2010 – ArQule, Inc. (NASDAQ: ARQL) and Daiichi Sankyo Co., Ltd. (TSE
4568) today announced the expansion of their research, development and
license agreement for the discovery of novel kinase inhibitors in the field
of oncology. This expanded agreement establishes a third therapeutic target,
with an option for a fourth, in the field of [...]

BiondVax Begins Phase IIa Study for Universal Flu Vaccine

NESS ZIONA, Israel, October 11, 2010 – BiondVax Pharmaceuticals Ltd. (TASE: BNDX) (www.biondvax.com/), an
Israeli biopharmaceutical company at the forefront of global efforts towards
the development of a Universal Influenza Vaccine, today announced that it has
begun to immunize subjects in a Phase IIa clinical trial of the
Multimeric-001 Universal Flu Vaccine candidate. The study will evaluate the
safety [...]

Global Experts Debate Solutions for Preventing Healthcare Acquired Infections at the 2010 International Conference of The Hospital Infection Society

ASP Sponsors Educational Symposium to Strengthen Infection Prevention Efforts and Promote Better Patient Care

LONDON, October 11, 2010 – At this week's international conference of the Hospital Infection Society
in Liverpool, United Kingdom, the world's leading experts in healthcare
acquired infections will gather to share their latest research and discuss
new ways of combatting diseases like MRSA and [...]

Shire Appoints Philip J. Vickers, PhD as Senior Vice President of Research & Development for Human Genetic Therapies Business

NYON, Switzerland and CAMBRIDGE, Massachusetts, October 11, 2010 – Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty
biopharmaceutical company, today announced that Philip J. Vickers, PhD, has
been appointed Senior Vice President of Research & Development (R&D) for its
Human Genetic Therapies (HGT) business. In this position, Dr. Vickers will be
responsible for leading global R&D for [...]

Abiraterone Acetate Significantly Improved Overall Survival for Patients With Metastatic Advanced Prostate Cancer

Note: Data in This Release Correspond to ESMO Abstract LBA5
BEERSE, Belgium, October 11, 2010 – Results from a pre-specified interim analysis of a randomised,
placebo-controlled Phase 3 study, COU-AA-301, demonstrate that patients
treated with the investigational agent abiraterone acetate plus low dose
prednisone/prednisolone showed a significant improvement in overall survival
compared to patients treated with prednisone/prednisolone plus placebo. [...]

Health Robotics Expands Operations Into Bosnia, Croatia, Finland, Macedonia, Montenegro, Serbia, and Slovenia

BOZEN, Sud-Tirol, Italy, October 11, 2010 – Health Robotics today announced that it recently signed exclusive
distribution agreements for its CytoCare, i.v.STATION, and i.v.SOFT
world-leading technologies in seven new European countries with regional
industry leaders Newico and Apta Medica, rapidly continuing on its worldwide
quest to pervasively provide safe and cost-effective Intravenous (IV)
Admixture Compounding Automation to hospitals all [...]

The Harley Medical Group Announces Rise in Breast Surgery Procedures in Ireland

DUN LOAGHAIRE, Ireland, October 11, 2010 – The Harley Medical Group, Ireland's leading cosmetic surgery provider,
has revealed breast surgery is top of the ops for the 23rd year running and
the fastest growing sector of cosmetic surgery. The Harley Medical Group has
seen a positive increase on last year's enquiries. While breast reductions
are becoming more popular [...]

Final Analysis of Landmark IPASS Study Confirms That IRESSA (Gefitinib) is a Valuable Option for the First-Line Treatment of Patients With Advanced NSCLC With EGFR Activating Mutations

MILAN, October 11, 2010 – This press release has been made available on worldwide (excluding US)
press communication media for the benefit of correspondents writing for the
medical professional press. Differing national legislation, codes of
practice, medical practice etc mean that you should contact your local AZ
press office to obtain information designed for use in your country.
Not [...]

Abbott Reports Psoriasis Phase III Results of its Investigational IL-12/23 Inhibitor Briakinumab (ABT-874)

Data Compares Briakinumab (ABT-874) to Etanercept, Methotrexate and Placebo in Psoriasis

ABBOTT PARK, Illinois, October 11, 2010 – In four separate pivotal clinical studies presented on Friday, a greater
percentage of moderate to severe chronic plaque psoriasis patients treated
with briakinumab, Abbott's investigational IL-12/23 inhibitor (ABT-874),
achieved 75 percent or better skin clearance rates than those treated with
etanercept [...]

HeartSine Technologies Honored With Belfast Ambassador Award at Belfast Business Top 50 Event

Award goes to the company for pioneering business in developing areas of Belfast.

STORMONT, BELFAST, Northern Ireland, October 11, 2010 – HeartSine Technologies, Inc. (www.heartsine.com) was honored with
the Belfast Ambassador Award at the sixth annual Belfast Business Top 50
event in Stormont, Belfast. The award was presented to the company by the
Belfast Media Group (belfastmedia.com) for [...]

Safety Confirmed of Breast Augmentation With Autologous Fat Stem Cells

Stem Cell-Enriched Autologous Fat Makes Permanent Natural Breast Enlargement

VIENNA, October 12, 2010 – Since 2003, breast augmentation utilizing stem cells from autologous fat
has been developed enabling silicon-free breast reconstruction following
cancer surgery. Till now though, it was unclear whether this might reactivate
the cancer again. However, University of Pittsburgh researchers led by Prof.
Albert Donnenberg have now [...]

Elsevier Announces Publishing of The American Journal of Pathology (AJP) on Behalf of the American Society for Investigative Pathology (ASIP)

PHILADELPHIA, October 12, 2010 – Elsevier, a world-leading publisher of scientific, technical and medical
information products and services, is pleased to announce that as of January
2011 Elsevier will publish The American Journal of Pathology (AJP) in
partnership with the American Society for Investigative Pathology (ASIP).

The American Journal of Pathology is the official [...]

Elsevier Announces Publishing of The Journal of Molecular Diagnostics, on Behalf of the Association for Molecular Pathology (AMP) and the American Society for Investigative Pathology (ASIP)

PHILADELPHIA, October 12, 2010 – Elsevier, a world-leading publisher of scientific, technical and medical
information products and services, is pleased to announce that as of January
2011 Elsevier will publish The Journal of Molecular Diagnostics (JMD) in
partnership with the Association for Molecular Pathology (AMP) and the
American Society for Investigative Pathology (ASIP).

The Journal [...]

Sirius Genomics and Golden Helix Collaborate on Companion Diagnostic Development

VANCOUVER and BOZEMAN, Montana, October 12, 2010 – Sirius Genomics, a developer of companion diagnostics, and Golden Helix,
a global leader in genetic analysis solutions, announced today a
collaboration under which Golden Helix will apply its expertise and
technologies in SNP and copy number variant analysis and predictive modeling
to advance development of Sirius' diagnostic pipeline.

[...]

One Month Until First Worldwide NET Cancer Awareness Day on November 10, 2010

1st Global Call-to-Action at www.netcancerday.org
NEW YORK, October 12, 2010 – The World NET Community announces the first Worldwide NET Cancer
Awareness Day on November 10, 2010 to raise awareness about cancers called
neuroendocrine tumors (NETs) and the need for timely detection and diagnosis.
More than 90% of all NET patients are incorrectly diagnosed and initially
treated for the [...]

Goodmans Solicitors Rebrand

LIVERPOOL, England, October 13, 2010 – Leading medical negligence and personal injury solicitors, Goodmans Law
(www.goodmanslaw.co.uk/) has completed a rebranding process to
complete their transition to a specialist medical negligence and personal
injury law firm.

Goodmans Law, based in Liverpool, has evolved into one of the largest
specialist firms in this area of law. Goodmans … Read : Goodmans Solicitors Rebrand.

Shire Acquires 99.21% of the Shares of Movetis N.V. and Announces Commencement of Squeeze-Out Tender Period

DUBLIN, October 13, 2010 – Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty
biopharmaceutical company, announces that its wholly owned subsidiary Shire
Holdings Luxembourg S.a.r.l. acquired 99.21% of the shares of Movetis NV on
October 12, 2010, following a successful tender offer launched in September
2010.

As previously announced, Shire will proceed with a …. Read the original article  : here.

New Line of Neonatal Blood Pressure Supplies Demonstrates Philips’ Commitment to Patient Safety

ANDOVER, Massachusetts, October 13, 2010 – Today Royal Philips Electronics (NYSE: PHG, AEX: PHI) launched its newest
line of neonatal blood pressure solutions. As the global leader in neonatal
monitoring, Philips designed the new line of neonatal cuffs, air hoses, and
upgrade kits specifically to prevent tragic misconnection errors that can
cause harm to the most vulnerable of … Read more : New Line of Neonatal Blood Pressure Supplies Demonstrates Philips' Commitment to Patient Safety.

Cell Biosciences to Acquire Convergent Bioscience

SANTA CLARA, California, October 13, 2010 – Cell Biosciences, Inc. today announced that it has entered into a
definitive agreement to acquire Convergent Bioscience Ltd. for approximately
U.S. $12 million in cash. The transaction is expected to close by the end of
October, 2010.

Convergent Bioscience was founded in 1995 and employs 45 people,
primarily …. Original article  : Cell Biosciences to Acquire Convergent Bioscience.

Almac Successfully Moves its Clinical Technologies Business Unit Into New North American Headquarters

SOUDERTON, Pennsylvania, October 13, 2010 – Almac announced today that its Clinical Technologies division has
successfully moved into the Almac Group's new North American Headquarters.
After groundbreaking of the 40-acre site in Souderton, PA on 23 July 2008,
the drug development firm has now completed the first phase of relocating
employees from three Almac business units to the … Read more »»».

Biopharma Leaders to Reveal Successful Strategies for China, India at the PharmAsia Summit in San Francisco

SAN FRANCISCO, October 13, 2010 – Elsevier Business Intelligence, publisher of PharmAsia News, IN VIVO and
"The Pink Sheet," today announced the agenda for Windhover's 2nd PharmAsia
Summit
(www.windhover.com/windhover/content/conferences/pharmasia.aspx)
(Oct. 25-26). This year's Summit will bring top biopharma leaders from
Asia and the U.S. to San Francisco to share what works and what doesn't in
China, India, Japan and the …. Original article  : Biopharma Leaders to Reveal Successful Strategies for China, India at the PharmAsia Summit in San Francisco.

Luminex Corporation Hosts Eighth Annual Planet xMAP Europe in Vienna

Two-Day Multiplexing Symposium Brings Together Leading Scientists to Discuss New Developments in Clinical Diagnostics and Life Science Research

OOSTERHOUT, Netherlands, October 13, 2010 – Luminex Corporation (Nasdaq: LMNX), today announced that it will host
Planet xMAP Europe 2010, its annual European multiplexing technology
symposium, October 20-21, 2010, at The Hofburg in Vienna, Austria. The event
will feature scientific … Read more >>>.

Frost & Sullivan Honours Fingerprint Cards AB with Product Line Strategy Award

LONDON, October 13, 2010 – The 2010 Frost & Sullivan Europe Product Line Strategy Award in
Fingerprint Verification Components and Systems is presented to Fingerprint
Cards AB (FPC).

(Logo: photos.prnewswire.com/prnh/20081117/FSLOGO)
(Logo: www.newscom.com/cgi-bin/prnh/20081117/FSLOGO)

"For more than a decade, FPC has been operating in the biometrics
industry with the prime … Read more : Frost & Sullivan Honours Fingerprint Cards AB with Product Line Strategy Award.

PneumRx, Inc. Announces CE Mark Approval for Its RePneu(R) Lung Volume Reduction Coil (LVRC(TM)) System

MOUNTAIN VIEW, California, October 13, 2010 – PneumRx, Inc. (www.pneumrx.com), a medical device company dedicated to
bringing innovation and improvements to the treatment of lung disease, today
announced that it has received CE Mark approval for its RePneu Lung Volume
Reduction Coil (LVRC) System to treat the later stages of emphysema.

The RePneu LVRC … Read more >>>.

550 People Across Europe Will Die Today From a Preventable Lung Disease

On World Spirometry Day, Doctors Urge Regular "MOT Tests for the Lungs"

LONDON, October 14, 2010 – With new data revealing 23 Europeans die each hour[i] from a preventable
lung condition, the European Respiratory Society (ERS) is calling on people
across Europe to get their lungs tested on the first ever World Spirometry
Day – 14th October.
…. Read the original article  : 550 People Across Europe Will Die Today From a Preventable Lung Disease.

Three-Year Follow-Up Data Confirm Safety and Survival Benefit in Chinese Liver Failure Patients Treated With ELAD(R) Bioartificial Liver

Poster presentation scheduled at AASLD November 2nd
SAN DIEGO, October 14, 2010 – Vital Therapies, Inc., (VTI) today announced that a poster is being
presented at the American Association for the Study of Liver Diseases (AASLD)
meeting in Boston on Tuesday, November 2nd. It confirms that previously
reported findings of improved transplant free survival (TFS) in Chinese
subjects with … Original article on : Three-Year Follow-Up Data Confirm Safety and Survival Benefit in Chinese Liver Failure Patients Treated With ELAD(R) Bioartificial Liver.

DaTSCAN(TM) (Ioflupane I 123 Injection) Recommended in Updated European Guidelines for Diagnosis of Alzheimer’s Disease

European Federation of the Neurological Societies Cites Utility of DaTSCAN in Differentiating Alzheimer's Disease from Dementia with Lewy Bodies

PRINCETON, New Jersey, October 14, 2010 – GE Healthcare, a unit of General Electric Company (NYSE: GE), today
announced that DaTSCAN(TM) (ioflupane I 123 injection), a radiopharmaceutical
agent intended for use with single photon emission computed tomography
(SPECT) imaging …. Source  : Gaea News Network.

The World Market for Diabetes Treatments Now Available at ReportsandReports

ReportsandReports Announces it Will Carry The World Market for Diabetes Treatments Research Report in its Store

DALLAS, October 14, 2010 – Browse the complete Report on:
www.reportsandreports.com/reports/35297-the-world-market-for-diabetes-
treatments.html
This Kalorama Information report , The World Market for Diabetes
Treatments, provides market estimates and forecasts for the world market for
diabetes treatments. The diabetes market is one … Read : The World Market for Diabetes Treatments Now Available at ReportsandReports.

First CyberKnife(R) System in Clinical Use in Czech Republic

Major Czech Academic Center Expands Care to Offer Radiosurgery
SUNNYVALE, California, October 14, 2010 – Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of
radiosurgery, today announced that the first CyberKnife Robotic Radiosurgery
System in Czech Republic is now treating cancer patients at the University
Hospital of Ostrava (UHO) Clinic of Oncology.

The … Read more »».

Teva UK Limited Comments on Department of Health Generic Substitution Outcome

CASTLEFORD, England, October 15, 2010 – Teva UK Limited, the UK's leading manufacturer of generic medicines, has
today commented on the Department of Health's (DH) decision not to implement
generic substitution in primary care.

Although deciding not to go ahead with generic substitution as the
original proposals stood, DH has indicated that it will … Read the original article on Gaea Times at : Teva UK Limited Comments on Department of Health Generic Substitution Outcome.